NIH-funded research R01 grant

CC16 in childhood and resilience to early airflow limitation in adulthood

Official title: CC16 in childhood and resilience to early airflow limitation in adult life

Funded at University of Arizona · NIH-11511724 · Data updated 2026-11-12

This grant explores how a protein called CC16 in childhood may protect against early lung problems that can lead to COPD later in life.

More Resilience research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startSeptember 25, 2017
Project endMarch 31, 2030
Funding year2026
Award (this year)$9,148
NIH project number3R01AI135108-07S2
Project IDNIH-11511724 on NIH RePORTER

Who could benefit from this research

Could help

Children and adults who are at risk for reduced lung growth or COPD development, or who have a history of early-life airway issues.

Less likely to help

Individuals without any history or risk of early lung function impairment may not directly benefit from this research.

What this research studies

Researchers are looking at how CC16, a protective protein in the airways, might guard against early lung changes that set the stage for COPD. The project follows people from childhood into adulthood to understand who stays healthier and why. By studying measuring CC16 levels and lung function, the team hopes to identify factors that confer resilience to poor lung growth. The work could point to new ways to prevent COPD by supporting lung health from an early age.

Why it matters

Potential benefit: If successful, findings could help prevent COPD by identifying individuals at risk early and guiding interventions to boost airway protection.

How similar studies have gone: Previous work suggests CC16 may have protective anti-inflammatory effects, but the specific role in resilience to early airway limitation is still being explored.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Guerra, Stefano — University of Arizona
  • Study coordinator: Guerra, Stefano

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.